Kymera Therapeutics KYMR SEC Filings

NASDAQ KYMR
$117.51 +0.23 (+0.20%)
As of: Sep 4, 2026 · 3:04 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Kymera Therapeutics, Inc. (KYMR) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index